income, page-5

Yep, That's how I read it, however, it just seems odd that once cardiocel started being sold, the quarterly income numbers went down. one answer may be fluctuations in the medical equipment sales that have absorbed the cardiocel dollars.

The company has more employees now than before, and we are sending them across the globe to sell the cardiocel story, which wont be an inexpensive exercise. Also, the employment of the newly appointed marketing staff (with their experience) would be adding to the staff cost ( I assume) but as I see it, money well spent.

The staff costs are considerable, but if capturing a considerable market share requires swift and decisive (and costly) proactive actions as apposed to trickling the product into the market in a gentle (and relying on existing staffing levels) way, I am sure that the marketing guru's have it under control. One could imagine that the recent staffing costs will reflect a critical mass of staff cost increases (which will hopefully plateau off), and now just waiting for the revenue to catch up.